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The setting of interest is that of longitudinal rando-
mized controlled clinical trials. The question of interest
is: why is it that trialists think that intervention affects
the mean but not the covariance structure? Trial design
and execution should be a multi-criteria activity (based
on joint mean-covariance modelling) and not merely
focussed on the mean (location) which, curiously, is
how most trials are designed today.
Often, the covariance structure is thought to be a
‘nuisance parameter’ or at least not to be of primary
‘scientific interest’ and little effort is expended on eluci-
dating its structure. The idea that intervention might
affect the covariance structure rather than, or as well as,
the mean rarely intrudes. We shall argue that these
ideas are rather pass´e and that from an inferential
standpoint the problem is symmetrical in both para-
meters. Throughout, we will distinguish carefully
between joint estimation which is now relatively routine
and joint model selection which is not.
At first sight the task of estimating the structure of
the covariance matrix, from the data, rather than from a
prespecified menu, may seem daunting, whence the idea
of searching the entire covariance model space may
seem prohibitive. Thus, the final demand that we con-
duct a simultaneous search of the Cartesian product of
the mean-covariance model space may seem impossible.
However, below, we shall accomplish all three tasks ele-
gantly for a particular, but very general, class of covar-
iance structures defined below.
We expect that the new models described will
improve current practice in the trials arena.
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